Everest Medicines Limited (6HN.F) Q3 2025 Earnings

27AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.24
-0.19
-0.14
-0.09

Details

Expected EPS
-0.12100734956999999
Actual EPS
-0.09225312789
Surprise EPS
0.03
Surprise Percent
+23.76%

Description

Everest Medicines Limited (6HN.F) has reported earnings of -0.09225312789 per share for Q3 2025.

0 Comments

Share your thoughts